Expert Comparison: 1.7mg Wegovy vs Mounjaro Pricing Guide
1.7mg Wegovy vs Mounjaro: Understanding Your Discount Code Options
When comparing 1.7mg Wegovy vs Mounjaro, securing the best pricing through discount codes becomes crucial for long-term treatment sustainability. New customers can apply code FIRST40 at checkout to access our listed prices, whilst returning patients use DOSE25 for continued savings. The 1.7mg Wegovy dose represents weeks 13-16 of your escalation schedule, positioning you perfectly to transition into maintenance therapy. Both medications require prescription-only access through our comprehensive clinical assessment process.
Your choice between 1.7mg Wegovy vs Mounjaro should consider not just immediate costs, but long-term value propositions. Wegovy utilises semaglutide as a GLP-1 receptor agonist, whilst Mounjaro employs tirzepatide as a dual GIP and GLP-1 receptor agonist. Both approaches have demonstrated significant efficacy in clinical trials when used alongside lifestyle modifications. Our discount codes ensure you access either treatment at competitive prices, supporting your continued progress towards maintenance therapy.
Pricing Breakdown: 1.7mg Wegovy vs Mounjaro Bundle Options
The 1.7mg Wegovy single pen costs £139.99 with discount codes applied at checkout, whilst our Consistency 1.7mg bundle (two pens) provides £309.99 value for extended supply. For patients planning their transition to maintenance, the Elevate Duo bundle combines 1.7mg and 2.4mg doses for £369.99, ensuring seamless progression. These prices reflect final costs after applying FIRST40 or DOSE25 codes during the checkout process.
Comparing 1.7mg Wegovy vs Mounjaro pricing requires understanding each medication's unique dosing schedules and maintenance requirements. Our bundle options provide convenience through fewer orders and Reliable Supply continuity, particularly valuable when approaching maintenance therapy. The 1.7mg dose represents a critical juncture where patients often experience accelerated results, making cost-effective access through our discount codes essential. Both treatments require ongoing prescription management through our GPhC #9012878 registered pharmacy services.
Clinical Evidence: 1.7mg Wegovy vs Mounjaro Trial Data
In clinical trials, patients taking Wegovy alongside diet and exercise achieved approximately 15% average weight loss at 68 weeks in the STEP 1 trial (Wilding et al., NEJM, 2021). The 1.7mg dose represents the penultimate escalation step, where many patients report enhanced satiety effects. Mounjaro's SURMOUNT trials demonstrated significant efficacy through its dual receptor agonist mechanism, though direct head-to-head comparisons between trials aren't appropriate due to different study designs and populations.
Both medications work through appetite regulation pathways, but utilise different mechanisms when comparing 1.7mg Wegovy vs Mounjaro effectiveness. Clinical evidence suggests both treatments may help support weight management when prescribed alongside lifestyle modifications. The 1.7mg Wegovy dose typically represents weeks 13-16, where patients often experience optimal balance between efficacy and tolerability before progressing to 2.4mg maintenance.
How 1.7mg Wegovy vs Mounjaro Work: Mechanism Differences
Wegovy contains semaglutide, a GLP-1 receptor agonist that mimics natural fullness hormones produced in your intestine. This mechanism reduces appetite by acting on brain appetite centres, promoting feelings of fullness after smaller meals, and may reduce food cravings throughout the day. The 1.7mg dose provides substantial receptor activation whilst maintaining tolerability for most patients. Mounjaro utilises tirzepatide, targeting both GIP and GLP-1 receptors simultaneously, creating a dual agonist approach to appetite regulation. Both treatments require once-weekly injection using pre-filled pen devices designed for self-administration.
Ordering Process: 1.7mg Wegovy vs Mounjaro Through EverydayMeds
Our streamlined ordering process for both 1.7mg Wegovy vs Mounjaro begins with a comprehensive 3-minute online clinical assessment covering your medical history, current medications, and weight management goals. Following submission, our prescribing team reviews your assessment within 3 working days (or 24 hours with express service) to determine treatment suitability. Upon approval, your prescription-only medicine ships via next-day delivery using cold-chain temperature-controlled packaging to maintain medication integrity. Remember to apply discount code FIRST40 (new customers) or DOSE25 (returning patients) at checkout to secure your pricing. Both medications arrive with detailed administration guidance and ongoing support from our clinical team.
Storage Advantages: 1.7mg Wegovy vs Mounjaro Practical Considerations
When comparing 1.7mg Wegovy vs Mounjaro storage requirements, Wegovy offers superior travel flexibility with 6 weeks room temperature stability below 30°C once removed from refrigeration, compared to Mounjaro's 21-day room temperature limit. Both medications require initial refrigerated storage between 2-8°C before first use, arriving in temperature-controlled packaging. The FlexTouch pen system used for Wegovy provides intuitive dose administration, whilst both treatments utilise similar once-weekly injection schedules. Your 1.7mg dose represents the penultimate step in Wegovy's five-dose escalation protocol, requiring 4-week intervals between increases. Proper storage ensures medication potency throughout your treatment journey, particularly important when transitioning between doses.
Long-term Planning: 1.7mg Wegovy vs Mounjaro Cost Optimisation
Planning your 1.7mg Wegovy vs Mounjaro long-term costs involves understanding maintenance therapy requirements beyond initial dose escalation. The 1.7mg Wegovy dose precedes 2.4mg maintenance, where many patients remain long-term, making our Elevate Duo bundle strategically valuable for transition planning. Our DOSE25 returning customer code ensures continued competitive pricing throughout your treatment journey. Both medications represent ongoing investments in health, requiring sustained commitment for optimal results.
Cost optimisation strategies for 1.7mg Wegovy vs Mounjaro include bundle purchasing for supply security and utilising our discount codes consistently. The 1.7mg dose typically spans weeks 13-16, positioning you four weeks from maintenance therapy where pricing predictability becomes crucial. Both treatments have demonstrated weight regain patterns following discontinuation, emphasising the importance of long-term affordability. Our flexible ordering system accommodates various planning approaches, whether you prefer individual pen purchases or bundle convenience.
Final Decision: Securing Your 1.7mg Wegovy vs Mounjaro Treatment
Your comparison of 1.7mg Wegovy vs Mounjaro concludes with actionable next steps through our streamlined ordering process. Apply discount code FIRST40 at checkout for new customer pricing, or DOSE25 for returning patient rates, ensuring access to competitive costs for either treatment option. Both medications are available through our GPhC #9012878 registered pharmacy with comprehensive clinical support throughout your journey. Visit https://everydaymeds.co.uk/products/wegovy-1-7mg to begin your assessment, knowing our prescribing team will help determine the most suitable option based on your individual circumstances. Remember, both treatments work most effectively alongside a reduced-calorie diet and increased physical activity, representing one component of comprehensive weight management strategy. Our clinical team provides ongoing support as you progress through dose escalation towards maintenance therapy, ensuring optimal treatment outcomes.
Reviewed by the EverydayMeds Clinical Team · GPhC #9012878 · Last updated February 2026
